Parag Mallick's most recent trade in Nautilus Biotechnology Inc was a trade of 12,000 Common Stock done at an average price of $0.7 . Disclosure was reported to the exchange on May 8, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nautilus Biotechnology Inc | Parag Mallick | Director, Chief Scientist, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.73 per share. | 08 May 2025 | 12,000 | 20,491,892 | - | 0.7 | 8,788 | Common Stock |
| Nautilus Biotechnology Inc | Parag Mallick | Director, Chief Scientist, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.73 per share. | 08 May 2025 | 1,500 | 20,493,392 | - | 0.7 | 1,098 | Common Stock |
| Nautilus Biotechnology Inc | Parag Mallick | Director, Chief Scientist, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 280,000 | 280,000 | - | - | Stock Option (Right to Buy) | |
| Nautilus Biotechnology Inc | Parag Mallick | Director, Chief Scientist, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 280,000 | 280,000 | - | - | Stock Option (Right to Buy) | |
| Nautilus Biotechnology Inc | Parag Mallick | Director, Chief Scientist, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 280,000 | 280,000 | - | - | Stock Option (Right to Buy) |